Skip Navigation

FLASH: Oxygen at Home Approvals for Medicare Advantage Members with COVID-19

Due to the 1135 Waiver, we have the flexibility to waive the current national and local coverage determinations that otherwise restrict coverage of the home-use of oxygen for the remainder of 2020. This change will allow practitioners the option of treating their patients with home-use of oxygen during the COVID-19 public health emergency. Unless further guidance is provided, we’ll return to enforcement of these clinical indications for coverage on January 1, 2021.

Codes impacted:

E1390 – O2 concentrator
E1392 – O2 portable concentrator
E0431 – portable O2 system
K0738 – portable O2 system
E0441 – O2 contents
E0442 – liquid O2 contents
E0443 – portable O2 contents
E0444 – liquid portable O2 contents

If you have any questions, please contact your provider relations specialist. And please visit for more information on COVID-19, including questions about coverage. Thank you for all you do for the care of our members.

View as PDF.